BriefTea
Every story in sixty words
Explained in plain English
The NHS and obesity costs
Obesity is a significant health challenge in the UK, costing the NHS billions annually through related conditions like type 2 diabetes and heart disease. Programmes like the Wegovy rollout aim to reduce these long-term costs and improve public health, but balancing the cost of new treatments with their benefits is always a complex decision for the NHS.
Stories that explain this
NHS weight loss jab patients face regaining weight from JanuaryRelated explainers
The cost of new medicines Why is there a two-year limit? What are Wegovy jabs? Weight loss drugs globally What about non-prescription costs? Why alcohol costs more Will all vapes cost more? Better NHS with AI?The full catalogue
Browse every card filed under N →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.